FGFR3 and breast cancer: In 2005, a retrospective study including 119 pT1 high grade BC – 16.8% with FGFR3 alterations and 65.5% with p53 mutations – did not detect any association of the mutated genes with RFS, CSS or clinicopathologic features (35).